Precision Genomic Intelligence

We combine advanced AI with deep genomic expertise to deliver clinical-grade interpretation, neonatal screening, and population health intelligence — at a fraction of legacy costs.

97%
Cost Reduction
<4h
Analysis Time
99.7%
Variant Precision
5
Integrated Products
Our Foundation

Forged in World-Class Genomics. Built for the World.

Genomatis was founded by engineers and scientists whose careers were shaped by some of the most ambitious genomic medicine programmes in the world — including the UK’s Genomic Medicine Service, where our founding team contributed to the data processing infrastructure behind the sequencing of over 100,000 genomes for rare disease and cancer patients.

That experience revealed a critical gap: while large-scale genomic medicine had been proven viable, the technology remained inaccessible to most of the world — locked behind prohibitive costs, slow turnaround times, and fragmented infrastructure.

Genomatis exists to close that gap. We took deep domain expertise in genomic data engineering and rebuilt the platform from the ground up — leveraging modern AI, cloud-native architecture, and scalable design to deliver clinical-grade genomic analysis at 2.6% of legacy costs for the analysis reports.

Today, our platform processes genomic data for hospitals, laboratories, government health programmes, and municipalities — bringing precision medicine to populations that have never had access to it before.

2018UK Genomic MedicineOur founders begin working on large-scale genomic data platforms within the UK’s national genomic medicine initiatives.
2021Expertise ProvenNational-scale genomic pipelines our team helped build go live, processing rare disease and cancer referrals for millions of patients in the UK.
2022Genomatis FoundedThe team sets out to democratise genomic medicine, starting with a complete new platform design using modern AI/ML.
2024Platform MaturityCore processing engine operational with AI-powered interpretation, achieving 99.7% variant classification precision.
2025Full Product SuiteFive integrated products launched, spanning clinical analysis, neonatal screening, population health, and municipal healthcare.
£700M+
UK Programme Our Team Contributed To
100K+
Genomes Our Expertise Helped Process
£85
Per Genome Analysis & Report
38x
Faster Than Legacy Systems
Product Suite

Five Products. One Integrated Platform.

Each product addresses a distinct clinical and commercial need — yet all share a common data backbone, AI engine, and compliance framework. Together, they cover the full lifecycle of genomic medicine.

Technology

Enterprise-Grade. Healthcare-Proven.

Every component of the Genomatis stack is selected for clinical reliability, regulatory compliance, and scalability. Production-hardened technology trusted in genomic medicine.

01

AI / ML Engine

PyTorch 2.x, genomic transformer models (DNABERT-2, ESM-2), LLMs for clinical NLP (fine-tuned Llama 3, ClinicalBERT), RAG with vector search (Milvus), and MLflow for model lifecycle management.

02

Processing Pipeline

FastAPI async backend (Python 3.12), Apache Airflow orchestration, Apache Kafka event streaming, containerised on Kubernetes with auto-scaling. Processes 50+ TB genomic data monthly.

03

Data Architecture

PostgreSQL 16 (transactional), TimescaleDB (time-series), MongoDB (semi-structured genomic data), Redis (caching), Elasticsearch (search), Apache Iceberg data lake on S3-compatible storage.

04

Healthcare Security

AES-256-GCM encryption at rest, TLS 1.3 + mTLS in transit, field-level encryption for PII/PHI, OAuth 2.0 + OIDC, RBAC/ABAC, hardware security modules (HSM), immutable audit logs with 7+ year retention.

05

Global Infrastructure

Multi-region Kubernetes deployment: Americas (primary), Europe (GDPR), Asia-Pacific. 99.99% uptime SLA, <5 min RTO, <30 sec RPO, with full disaster recovery and cross-region replication.

06

Observability

Prometheus + Thanos (metrics), Grafana Enterprise (dashboards), OpenTelemetry + Jaeger (distributed tracing), ELK + Loki (logging), Sentry (error tracking), PagerDuty (alerting).

Market Opportunity

Serving a $41B Market Across Multiple Segments

Genomatis products address distinct buyer segments, each representing billions in addressable revenue.

Hospitals & Health Systems

Clinical genomic analysis for rare disease diagnosis, oncology profiling, and pharmacogenomic testing. Replacing manual, vendor-locked workflows with an integrated cloud platform.

Up to £863K per network annually

Clinical Laboratories

High-throughput genomic analysis at scale. Laboratories performing 150,000+ genetic tests annually require platform-grade infrastructure.

Up to £1.99M per laboratory annually

Government & Public Health

National genome programmes, newborn screening mandates, and municipal healthcare modernisation. Brazil’s R$23B AI investment plan creates an immediate addressable market.

Multi-year government contracts

Academic & Research Institutions

Universities, research hospitals, and biobanks conducting genomic research at scale. Federated data access and population analytics tools.

Up to £1.66M per institution annually
Compliance & Security

Built for the Most Regulated Industry on Earth

Healthcare genomic data is the most sensitive information that exists. Our platform is architected from the ground up for regulatory compliance — not retrofitted.

HIPAA
US Health Data Protection
GDPR
EU Data Residency & Privacy
LGPD
Brazilian Data Protection
ISO 27001
Information Security Management
SOC 2 Type II
Trust Services Criteria
21 CFR Part 11
FDA Electronic Records
AES-256 + TLS 1.3
End-to-End Encryption
7-Year Audit Trail
Immutable, Tamper-Proof Logs

Advancing Genomic Medicine, Together

Whether you are a hospital seeking better diagnostics, a government building a national programme, or a municipality transforming citizen healthcare — we have a solution designed for your scale.